Literature DB >> 31759074

Bringing FLASH to the Clinic: Treatment Planning Considerations for Ultrahigh Dose-Rate Proton Beams.

Patricia van Marlen1, Max Dahele1, Michael Folkerts2, Eric Abel2, Berend J Slotman1, Wilko F A R Verbakel3.   

Abstract

PURPOSE: Preclinical research into ultrahigh dose rate (eg, ≥40 Gy/s) "FLASH"-radiation therapy suggests a decrease in side effects compared with conventional irradiation while maintaining tumor control. When FLASH is delivered using a scanning proton beam, tissue becomes subject to a spatially dependent range of dose rates. This study systematically investigates dose rate distributions and delivery times for proton FLASH plans using stereotactic lung irradiation as the paradigm. METHODS AND MATERIALS: Stereotactic lung radiation therapy FLASH-plans, using 244 MeV scanning proton transmission beams, with the Bragg peak behind the body, were made for 7 patients. Evaluated parameters were dose rate distribution within a beam, overall irradiation time, number of times tissue is irradiated, and quality of the FLASH-plans compared with the clinical volumetric-modulated arc therapy (VMAT) plans.
RESULTS: Sparing of lungs, thoracic wall, and heart in the FLASH-plans was equal to or better than that in the VMAT-plans. For a spot peak dose rate (SPDR, the dose rate in the middle of the spot) of 100 Gy/s, ∼40% of dose is delivered at FLASH dose rates, and for SPDR = 360 Gy/s this increased to ∼75%. One-hundred percent FLASH dose rate cannot be achieved owing to small contributions from distant spots with lower dose rates. The total irradiation time varied between 300 to 730 ms, and around 85% of the dose-receiving body volume was irradiated by either 1 or 2 beams.
CONCLUSIONS: Clinical implementation of FLASH using scanning proton beams requires multiple treatment planning considerations: dosimetric, temporal, and spatial parameters all seem important. The FLASH efficiency of a scanning proton beam increases with SPDR. The methodology proposed in this proof-of-principle study provides a framework for evaluating the FLASH characteristics of scanning proton beam plans and can be adapted as FLASH parameters are better defined. It currently seems logical to optimize plans for the shortest delivery time, maximum amount of high dose rate coverage, and maximum amount of single beam and continuous irradiation.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31759074     DOI: 10.1016/j.ijrobp.2019.11.011

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  20 in total

1.  Model studies of the role of oxygen in the FLASH effect.

Authors:  Vincent Favaudon; Rudi Labarbe; Charles L Limoli
Journal:  Med Phys       Date:  2021-08-18       Impact factor: 4.071

Review 2.  Updates and new directions in the use of radiation therapy for the treatment of pancreatic adenocarcinoma: dose, sensitization, and novel technology.

Authors:  William A Hall; Mandana Kamgar; Beth A Erickson; Sara Beltrán Ponce; Susan Tsai; Marja T Nevalainen; Kathleen K Christians; Ben George; Kulwinder S Dua; Abdul H Khan; Douglas B Evans; Asfar S Azmi
Journal:  Cancer Metastasis Rev       Date:  2021-10-06       Impact factor: 9.237

3.  Simultaneous dose and dose rate optimization (SDDRO) of the FLASH effect for pencil-beam-scanning proton therapy.

Authors:  Hao Gao; Jiulong Liu; Yuting Lin; Gregory N Gan; Guillem Pratx; Fen Wang; Katja Langen; Jeffrey D Bradley; Ronny L Rotondo; Harold H Li; Ronald C Chen
Journal:  Med Phys       Date:  2021-12-07       Impact factor: 4.506

4.  Ultra-high dose rate radiation production and delivery systems intended for FLASH.

Authors:  Jonathan Farr; Veljko Grilj; Victor Malka; Srinivasan Sudharsan; Marco Schippers
Journal:  Med Phys       Date:  2022-05-05       Impact factor: 4.506

Review 5.  The impact of proton therapy on cardiotoxicity following radiation treatment.

Authors:  Andrew J Frankart; Rajaram Nagarajan; Luke Pater
Journal:  J Thromb Thrombolysis       Date:  2020-10-08       Impact factor: 2.300

6.  DNA strand break induction of aqueous plasmid DNA exposed to 30 MeV protons at ultra-high dose rate.

Authors:  Daisuke Ohsawa; Yota Hiroyama; Alisa Kobayashi; Tamon Kusumoto; Hisashi Kitamura; Satoru Hojo; Satoshi Kodaira; Teruaki Konishi
Journal:  J Radiat Res       Date:  2022-03-17       Impact factor: 2.724

7.  SDDRO-joint: simultaneous dose and dose rate optimization with the joint use of transmission beams and Bragg peaks for FLASH proton therapy.

Authors:  Yuting Lin; Bowen Lin; Shujun Fu; Michael M Folkerts; Eric Abel; Jeffrey Bradley; Hao Gao
Journal:  Phys Med Biol       Date:  2021-06-14       Impact factor: 4.174

Review 8.  Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?

Authors:  Joseph D Wilson; Ester M Hammond; Geoff S Higgins; Kristoffer Petersson
Journal:  Front Oncol       Date:  2020-01-17       Impact factor: 6.244

9.  Multi-Institutional Retrospective Analysis of the Outcomes of Proton Beam Therapy for Patients With 1 to 3 Pulmonary Oligometastases From Various Primary Cancers.

Authors:  Norihiro Aibe; Hiroyuki Ogino; Satoshi Teramukai; Hideya Yamazaki; Hiromitsu Iwata; Yoshiro Matsuo; Tomoaki Okimoto; Masao Murakami; Motohisa Suzuki; Takeshi Arimura; Takashi Ogino; Shigeyuki Murayama; Hideyuki Harada; Masaki Nakamura; Tetsuo Akimoto; Hideyuki Sakurai
Journal:  Adv Radiat Oncol       Date:  2021-03-26

Review 10.  Roadmap: proton therapy physics and biology.

Authors:  Harald Paganetti; Chris Beltran; Stefan Both; Lei Dong; Jacob Flanz; Keith Furutani; Clemens Grassberger; David R Grosshans; Antje-Christin Knopf; Johannes A Langendijk; Hakan Nystrom; Katia Parodi; Bas W Raaymakers; Christian Richter; Gabriel O Sawakuchi; Marco Schippers; Simona F Shaitelman; B K Kevin Teo; Jan Unkelbach; Patrick Wohlfahrt; Tony Lomax
Journal:  Phys Med Biol       Date:  2021-02-26       Impact factor: 4.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.